Birmingham Rheumatology Research Patient Partnership (R2P2)

R2P2 group

We believe that patients should have a say in research that is potentially for their benefit.

The Birmingham Rheumatology Research Patient Partnership (R2P2) is a group of patients who are actively involved in the work of the Rheumatology Research Group in the Institute of Inflammation and Ageing, University of Birmingham. R2P2 members advise our researchers about what research we should do, how we should go about it and how we can share it with the public.

Below you will find links to relevant information about R2P2 and the work that R2P2 contributes to. If you are interested in joining and becoming a patient research partner, please contact Becky Birch.

An interview with an R2P2 patient research partner, talking about her experiences of being involved with rheumatology research

Find out more about the Birmingham Rheumatology Research Patient Partnership

Latest news and updates

R2P2 Meeting 2024

Dear all, 
We are very happy to announce that the next R2P2 meeting is happening on the 23rd of May 2024 (10-2pm with arrival from 9.30) on the University of Birmingham, Edgbaston campus. Program includes talks from researchers, a ultrasound demonstration, lunch and opportunities for discussions. The meeting is hybrid, so there is also an opportunity to join online. If you like to know more or sign up, please contact Becky Birch
Looking forward to seeing many of you there!

Rheumatology Research Group Brochure

RRG reportSome of our patient research partners have worked with us to produce a new brochure describing the Rheumatology Research Group at the University of Birmingham - the brochure is available to download here.

The brochure is designed to share our research activities with the wider public and promote our patient partnership. Hopefully this will encourage people who are interested in our research to join R2P2! Please share with all who might be interested. If you would like a printed copy, please contact Becky Birch at

See past news and updates.

Latest Tweets